Page last updated: 2024-08-17

lactose and Bronchiectasis

lactose has been researched along with Bronchiectasis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abisheganaden, JA; Chandrasekaran, R; Chotirmall, SH; Hadinoto, K; Koh, MS; Lim, AYH; Low, TB; Roizman, D; Tan, GL; Teo, J; Tran, TT; Vidaillac, C; Yong, VFL; Yu, H	1
Krofton, DV	1

Other Studies

2 other study(ies) available for lactose and Bronchiectasis

Article	Year
A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart. International journal of pharmaceutics, 2018, Aug-25, Volume: 547, Issue:1-2 Topics: Administration, Inhalation; Anti-Bacterial Agents; Bronchiectasis; Case-Control Studies; Chemistry, Pharmaceutical; Ciprofloxacin; Drug Delivery Systems; Dry Powder Inhalers; Excipients; Humans; Lactose; Lung; Mannitol; Mucus; Permeability; Pseudomonas aeruginosa	2018
[Chemotherapy of respiratory diseases]. Antibiotiki, 1971, Volume: 16, Issue:8 Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Bronchiectasis; Bronchitis; Cephaloridine; Chloramphenicol; Chronic Disease; Cloxacillin; Erythromycin; Humans; Lactose; Methicillin; Oxytetracycline; Penicillin G; Penicillin Resistance; Pneumonia; Pneumonia, Staphylococcal; Pneumonia, Viral; Streptomycin; Tetracycline	1971

Article

Year

A new therapeutic avenue for bronchiectasis: Dry powder inhaler of ciprofloxacin nanoplex exhibits superior ex vivo mucus permeability and antibacterial efficacy to its native ciprofloxacin counterpart.

International journal of pharmaceutics, 2018, Aug-25, Volume: 547, Issue:1-2

Topics: Administration, Inhalation; Anti-Bacterial Agents; Bronchiectasis; Case-Control Studies; Chemistry, Pharmaceutical; Ciprofloxacin; Drug Delivery Systems; Dry Powder Inhalers; Excipients; Humans; Lactose; Lung; Mannitol; Mucus; Permeability; Pseudomonas aeruginosa

2018

[Chemotherapy of respiratory diseases].

Antibiotiki, 1971, Volume: 16, Issue:8

Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Bronchiectasis; Bronchitis; Cephaloridine; Chloramphenicol; Chronic Disease; Cloxacillin; Erythromycin; Humans; Lactose; Methicillin; Oxytetracycline; Penicillin G; Penicillin Resistance; Pneumonia; Pneumonia, Staphylococcal; Pneumonia, Viral; Streptomycin; Tetracycline

1971